LegalView.com Updates Avandia Information Portal
LegalView.com recently updated its Web portal concerning new risks associated with the use of Avandia in Type II diabetes patients. In a recent study out of the Salk Institue for Biological Studies in La Jolla, California has found that long term use of Avandia, also known as rosiglitazone, causes an increase in bone fractures and breaks among patients who use it. Tests showed that the drug increased bone degradation cell activity. GlaxoSmithKline, makers of Avandia, acknowledge the increased risk of bone fractures and breaks among patients taking the drug, especially in older women, but the company did little to make users aware of this increased risk. LegalView.com remains the premiere site for legal information and its many legal information portals are used to serve people suffering from preventable diseases, illness and unfortunate accidents.
